165 related articles for article (PubMed ID: 30846413)
1. Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.
Cao J; Yang T; Tang D; Zhou F; Qian Y; Zou X
Pathol Res Pract; 2019 May; 215(5):1012-1019. PubMed ID: 30846413
[TBL] [Abstract][Full Text] [Related]
2. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.
Cheng IK; Tsang BC; Lai KP; Ching AK; Chan AW; To KF; Lai PB; Wong N
J Pathol; 2012 Dec; 228(4):575-85. PubMed ID: 22847784
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
4. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge.
Nalbant P; Chang YC; Birkenfeld J; Chang ZF; Bokoch GM
Mol Biol Cell; 2009 Sep; 20(18):4070-82. PubMed ID: 19625450
[TBL] [Abstract][Full Text] [Related]
5. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
6. Role of guanine nucleotide exchange factor-H1 in complement-mediated RhoA activation in glomerular epithelial cells.
Mouawad F; Aoudjit L; Jiang R; Szaszi K; Takano T
J Biol Chem; 2014 Feb; 289(7):4206-18. PubMed ID: 24356971
[TBL] [Abstract][Full Text] [Related]
7. Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis.
Hu Q; Lai J; Chen H; Cai Y; Yue Z; Lin H; Sun L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834937
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity.
von Thun A; Preisinger C; Rath O; Schwarz JP; Ward C; Monsefi N; Rodríguez J; Garcia-Munoz A; Birtwistle M; Bienvenut W; Anderson KI; Kolch W; von Kriegsheim A
Mol Cell Biol; 2013 Nov; 33(22):4526-37. PubMed ID: 24043311
[TBL] [Abstract][Full Text] [Related]
9. Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA.
Jiu Y; Peränen J; Schaible N; Cheng F; Eriksson JE; Krishnan R; Lappalainen P
J Cell Sci; 2017 Mar; 130(5):892-902. PubMed ID: 28096473
[TBL] [Abstract][Full Text] [Related]
10. Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.
Yamahashi Y; Saito Y; Murata-Kamiya N; Hatakeyama M
J Biol Chem; 2011 Dec; 286(52):44576-84. PubMed ID: 22072711
[TBL] [Abstract][Full Text] [Related]
11. BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation.
Pan M; Chew TW; Wong DCP; Xiao J; Ong HT; Chin JFL; Low BC
Sci Adv; 2020 Jul; 6(31):eaaz1534. PubMed ID: 32789168
[TBL] [Abstract][Full Text] [Related]
12. GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA.
Chang YC; Nalbant P; Birkenfeld J; Chang ZF; Bokoch GM
Mol Biol Cell; 2008 May; 19(5):2147-53. PubMed ID: 18287519
[TBL] [Abstract][Full Text] [Related]
13. The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.
Tsapara A; Luthert P; Greenwood J; Hill CS; Matter K; Balda MS
Mol Biol Cell; 2010 Mar; 21(6):860-70. PubMed ID: 20089843
[TBL] [Abstract][Full Text] [Related]
14. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.
Guo F; Tang J; Zhou Z; Dou Y; Van Lonkhuyzen D; Gao C; Huan J
Mol Immunol; 2012 Feb; 50(1-2):98-107. PubMed ID: 22226472
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathways.
Azoitei ML; Noh J; Marston DJ; Roudot P; Marshall CB; Daugird TA; Lisanza SL; Sandí MJ; Ikura M; Sondek J; Rottapel R; Hahn KM; Danuser G
J Cell Biol; 2019 Sep; 218(9):3077-3097. PubMed ID: 31420453
[TBL] [Abstract][Full Text] [Related]
16. Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.
Dan Q; Shi Y; Rabani R; Venugopal S; Xiao J; Anwer S; Ding M; Speight P; Pan W; Alexander RT; Kapus A; Szászi K
J Biol Chem; 2019 Oct; 294(42):15446-15465. PubMed ID: 31481470
[TBL] [Abstract][Full Text] [Related]
17. The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium.
Kakiashvili E; Dan Q; Vandermeer M; Zhang Y; Waheed F; Pham M; Szászi K
J Biol Chem; 2011 Mar; 286(11):9268-79. PubMed ID: 21212278
[TBL] [Abstract][Full Text] [Related]
18. Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF.
Yoshida T; Tsujioka M; Honda S; Tanaka M; Shimizu S
Oncotarget; 2016 Jun; 7(23):34420-9. PubMed ID: 27120804
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the type III effector VopO and GEF-H1 activates the RhoA-ROCK pathway.
Hiyoshi H; Okada R; Matsuda S; Gotoh K; Akeda Y; Iida T; Kodama T
PLoS Pathog; 2015 Mar; 11(3):e1004694. PubMed ID: 25738744
[TBL] [Abstract][Full Text] [Related]
20. The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets.
Comer S; Nagy Z; Bolado A; von Kriegsheim A; Gambaryan S; Walter U; Pagel O; Zahedi RP; Jurk K; Smolenski A
J Thromb Haemost; 2020 Nov; 18(11):3002-3012. PubMed ID: 32692911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
